PUBLISHER: Allied Market Research | PRODUCT CODE: 1239535
PUBLISHER: Allied Market Research | PRODUCT CODE: 1239535
The global external urine management products market is envisioned to garner $31,929.3 million by 2031, growing from $15,940 million in 2021 at a CAGR of 7.4% from 2022 to 2031.
An external urine management product is defined as a product or catheter that attaches to the perineum. External urine management product is mainly used for urine collection in both men and women with urinary incontinence (UI). The catheterization approach is chosen based on the underlying bladder problem, treatment goals, and gender appropriateness. All these factors are estimated to drive the market growth and demand during the forecast period.
External urine management such as catheterization involve difficult procedures. The insertion and removal of insufficiently lubricated catheters may generate friction between both the urethral walls and the edge of the device, which is not only uncomfortable for the patient but may also lead to urethral narrowing, bleeding, and infection with continued usage. Such factors are estimated to limit the market growth during the forecast period.
The use of external urine management products is mainly for urine incontinence (UI) and urinary retention (UR). Urinary incontinence is the unintentional loss of urine due to either stress incontinence in urine with activity such as laughing, overflowing, or coughing, or urgency incontinence urinary leakage without the activity of coughing or overflowing. Prostate cancer is becoming more common in older men around the world. Urinary incontinence (UI) can be caused by the curative treatments used by doctors to treat this type of cancer. Men who have received radiation or surgery for prostate cancer are more likely to get UI. In some cases, such therapy approaches can harm the muscles and nerves involved in regulating urine functions, causing patients to lose bladder control for life. These factors are driving the global demand for external urine management products market share.
The COVID-19 pandemic brought several uncertainties, leading to severe economic losses as various businesses across the world were at a standstill. The COVID-19 pandemic negatively impacted the manufacturing and supply chain & logistics industries. It also adversely affected the healthcare business. The implementation of social distancing norms and the modification of standard operating protocols have impeded the daily operations of several healthcare facilities around the world. The external urine management products market is growing as a result of major efforts made by healthcare providers and market stakeholders. The global market is driven by the rise in incidence of urinary incontinence and an aging population (people have difficulties passing urine normally in old age).Manufacturers in the global external urine management products market are focusing on new advancements and boosting the production of external urine management products due torisein global demand.
The key players profiled in this report include: Teleflex, Inc., Tilla Care, Inc., Consure Medical, Men's Liberty (BioDerm), Boehringer Laboratories, LLC, Hollister, Inc., Coloplast Corp., Sterimed Group, B. Braun Melsungen AG, and Cardinal Health.